Eli Lilly & Co. has surged about 300% since its first GLP-1 was approved over four years ago, propelling it past $1 trillion in market value and making it the world’s most valuable pharmaceutical company.
Eli Lilly & Co. has surged about 300% since its first GLP-1 was approved over four years ago, propelling it past $1 trillion in market value and making it the world’s most valuable pharmaceutical company.
<iframe src="https://statesidedaily.com/embed/cluster/3faba0db50d97fdf290fba828de3d5f37aa2d506" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Lilly’s Newest Bull Says Near 300% Rally Is Only the Beginning"></iframe>
